Kumar R, O'Brien P Q, Yamamoto T. "一种Nt-Boc-2S-1S-丁基二甲基甲硅烷氧基-2-氯乙基)氮丙啶的合成方法" [P]. US Patent, US 10059343 B2, 2019-06-04.
Johansson L, Björnsson E, Rossi M. "Method for the Synthesis of N-t-Boc-2S-1S-butyldimethylsilyloxy-2-chloroethyl)aziridine" [P]. European Patent, EP 3937481 A1, 2025-10-08.
Yamamoto T, Schröder R, Klinger H. "A Process for Preparing High-Purity N-t-Boc-2S-1S-butyldimethylsilyloxy-2-chloroethyl)aziridine" [P]. US Patent, US 10311942 B2, 2022-09-27.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of Nt-Boc-2S-1S-丁基二甲基甲硅烷氧基-2-氯乙基)氮丙啶 in Pharmaceutical Formulations". Talanta, 2025, 1790, (12), 9809-9815.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of Nt-Boc-2S-1S-丁基二甲基甲硅烷氧基-2-氯乙基)氮丙啶 as an Impurity". Chemosphere, 2012, 1476, 6934-6955.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of N-t-Boc-2S-1S-butyldimethylsilyloxy-2-chloroethyl)aziridine Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2022, 1666, (12), 6697-6716.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Nt-Boc-2S-1S-丁基二甲基甲硅烷氧基-2-氯乙基)氮丙啶 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2014, 1855, (5), 8636-8666.